Gnpal Speciality Molecules Llp Profile
Key Indicators
- Obligation of Contribution ₹ 2.00 Cr
- Company Age 3 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 44.25 Cr
About Gnpal Speciality Molecules Llp
Gnpal Speciality Molecules Llp (GSML) is 3 Year, 11 Months old Limited Liability Partnership 23 March 2021. Its registered office is in Nainital, Uttarakhand, India.
The LLP status is Active, and it has filed its Accounts and Solvency Statement up to 31 Mar 2023 (FY 2022-2023). It's Total Obligation of Contribution is Rs 2.00 Cr as per MCA.
Company Details
- Location
Nainital, Uttarakhand, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN/FCRN
AAW-4426
- Incorporation Date
23 Mar 2021
- Date of Accounts and Solvency Statement
31 Mar 2023
- ROC Code
Roc-Uttarakhand
- Company Classification
Limited Liability Partnership
Industry
Who are the key members and board of directors at Gnpal Speciality Molecules Llp?
Designated Partners (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gopal Pal  | Designated Partner | 23-Mar-2021 | Current |
| Neha Pal | Designated Partner | 23-Mar-2021 | Current |
| Ojaswa Pal | Designated Partner | 23-Mar-2021 | Current |
| Tanishq Pal | Designated Partner | 20-Aug-2021 | Current |
Financial Performance of Gnpal Speciality Molecules Llp.
Gnpal Speciality Molecules Llp, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Gnpal Speciality Molecules Llp?
Unlock access to Gnpal Speciality Molecules Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Pal Stone Industries Private LimitedGopal Pal is a mutual person
Charges (Loans)
₹44.25 Cr
₹0
Charges Breakdown by Lending Institutions
- Punjab National Bank : 29.25 Cr
- State Bank Of India : 15.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Sep 2023 | State Bank Of India | ₹15.00 Cr | Open |
| 14 Oct 2022 | Punjab National Bank | ₹4.25 Cr | Open |
| 14 Oct 2022 | Punjab National Bank | ₹25.00 Cr | Open |
How Many Employees Work at Gnpal Speciality Molecules Llp?
Gnpal Speciality Molecules Llp has a workforce of 107 employees as of Feb 06, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gnpal Speciality Molecules Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gnpal Speciality Molecules Llp's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.